D. Horvath

Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma

J. Lang, D. McNeel, G. Wilding, 2011, Cancer Immunology, Immunotherapy.

Phase I trial of 1α-hydroxyvitamin D2 in patients with hormone refractory prostate cancer

R. Mazess, G. Wilding, R. Bruskewitz, 2002 .

Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma

G. Wilding, D. Alberti, K. M. Kim, 2006, Investigational New Drugs.

Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.

R. Mazess, G. Wilding, R. Bruskewitz, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer

C. Yiannoutsos, G. Wilding, J. Kolesar, 2005, Clinical Cancer Research.

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.

D. McNeel, G. Wilding, J. Eickhoff, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer

D. McNeel, G. Wilding, J. Eickhoff, 2008, Clinical Cancer Research.

Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer

D. DeMets, G. Wilding, H. Bailey, 2003, Investigational New Drugs.

A phase I study of a DNA vaccine targeting prostatic Acid phosphatase in patients with stage D0 prostate cancer.

D. McNeel, G. Wilding, J. Eickhoff, 2005, Clinical genitourinary cancer.

Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer

D. McNeel, G. Wilding, J. Eickhoff, 2008, Clinical Cancer Research.